Big pharma already hedging risk to reduce reliance on China: Zuellig Pharma

featured-image

John Graham, Group CEO of Zuellig Pharma, shares how big pharmaceutical companies are taking steps to mitigate the fallout from new U.S. tariffs.

John Graham, Group CEO of Zuellig Pharma, shares how big pharmaceutical companies are taking steps to mitigate the fallout from new U.S. tariffs.

.